ArticleAlzheimer's & dementia (New York, N. Y.)2022

Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies.

Fernando L Pagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.